FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Strides Pharma Science Limited
Strides Pharma Science Limited announced the FDA approval of its generic Hydrocodone Bitartrate and Acetaminophen products, a move anticipated to invite immediate price competition and pressure competitors to defend their market share in the schedule II segment.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day